​***If you're a T2B member and do not receive your confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the cal invite.***

​T2Bmeet pricing:

• ​Complimentary for T2B Pro and Student community members (log into your T2B account and access your promo code here)

• ​$50 for Basic members

​If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:

​T2B Intake Form

​Join us for our first in-person meetup in Boston of 2026! In addition to the casual networking that T2B events are known for, we're kicking off the new year with a panel discussion. Open to all biopharma communicators in the T2B community.

​Program:

• ​4:30-5:30 p.m. - Check-in and networking

• ​5:30-6:15 p.m. - Panel discussion and Q&A

• ​6:15-7 p.m. - Reception and networking

​Complimentary snacks and drinks will be provided. ​See you there!

​Communications Career Choices That Compound

​Career growth in biopharma communications requires strategic choices beyond technical excellence. We're experienced professionals navigating cross-functional partnerships, developing well-rounded capabilities, and leading teams through continuous organizational change. The challenge comes when there's limited guidance on critical decisions: when to broaden versus deepen expertise, how to stay essential through volatility, and how to build influence that survives restructuring and market shifts. This panel examines the career strategy decisions and leadership development approaches that position communications professionals as indispensable strategic partners, not just skilled practitioners.

​Takeaways:

• ​Develop comprehensive capabilities across communications disciplines through intentional choices about when to specialize deeply versus when to expand your strategic range

• ​Examine how cross-functional business fluency earns you strategic partnership in C-suite decisions beyond communications execution

• ​Lead teams effectively through organizational volatility when budget pressures and restructuring create constant workforce fluctuations

• ​Explore how ongoing mentorship practices—including peer and reverse mentoring—keep senior leaders adaptable in rapidly evolving industry and communications landscapes

​About Our Host, Vertex

​Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

​Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 16 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex’s history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.